news & Services

Short Cases

TricValve® Case Madrid

Ramón y Cajal University Hospital

TricValve® Case Salamanca

University Hospital of Salamanca

TricValve® Case Saudi Arabia

Prince Sultan Cardiac Centre

PRESS RELEASEs

SINGAPORE, October 2021

THE STRAITS TIMES: More minimally invasive treatment options available in S´pore for patients with leaky heart valve

Vienna, February 24th 2022

P+F Products + Features goes U.S. – first implantation of the TricValve  Transcatheter Bicaval Valves System

Vienna, May 18th 2021

P+F Products + Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System

VIENNA, December 22nd 2020

TricValve® Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)

Publications

Downloads

TRICVALVE®

VIENNA AORTIC

Media Library

TRICVALVE®

TricValve® - Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux.

TRICUSPID REGURGITATION

In this short summary, Hon. Prof. Dr. Katharina Kiss talks about what you need to know about tricuspid regurgitation and current therapy

This site is intended for healthcare professionals.
Are you a healthcare professional?